NCT06199869 - Cardiovascular Patients With no Standard Modifiable Risk Factors | Biotech Hunter

Enrollment

5,540

Participants

Timeline

Start Date

January 22, 2024

Primary Completion Date

January 1, 2025

Study Completion Date

January 31, 2025

Conditions

Cardiovascular Risk Factors

Interventions

OTHER

Evaluation of risk factors by direct interview with subjects who have atherosclerotic cardiovascular patients

Individuals identified with a diagnosis of ASCVD will fill a one page form of the associated risk factors they have

Trial Locations (2)

Istishari Hospital, Amman

Yarmouk University School of Medicine, Irbid

All Listed Sponsors

collaborator

The Jordan Cardiovascular Research Group JoCVRG

OTHER

collaborator

Yarmouk University School of Medicine

UNKNOWN

lead

Jordan Collaborating Cardiology Group

OTHER